Technology area: Biotechnology & Pharmaceuticals
5 pending office actions • 3 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready
Trait Biosciences, Inc. has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned across 4 examiners and 3 art units, indicating examiner dispersion within a relatively limited set of technical groups.
DEVEAU ROSEN, JASON is the busiest examiner, with 1 pending matter. No examiner has a recurring concentration in the reported data, so prosecution planning can remain focused on the individual applications.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 2 (40%) |
| Double-patenting + other | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KOVALENKO, MYKOLA V | 2 | 69.6% | +25.5% |
| DEVEAU ROSEN, JASON | 1 | 80.0% | +16.3% |
| FETTEROLF, BRANDON J | 1 | 51.6% | +18.5% |
| MOEHLMAN, ANDREW TERRY | 1 | 67.0% | +59.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19290958 | Novel Systems, Methods, And Compositions For The Glycosylation Of Cannabinoid Compounds | DEVEAU ROSEN, JASON | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18678152 | WATER-SOLUBLE CANNABINOID PRODRUGS COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME | FETTEROLF, BRANDON J | — |
| 18430133 | PRODUCTION OF CANNABINOID GLYCOSIDE COMPOUNDS IN CELL CULTURE | KOVALENKO, MYKOLA V | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17189063 | Compositions And Methods For Glycosylating Cannabinoid Compounds | KOVALENKO, MYKOLA V | 11d overdue |
| 19290958 | Novel Systems, Methods, And Compositions For The Glycosylation Of Cannabinoid Compounds | DEVEAU ROSEN, JASON | — |
| 18678152 | WATER-SOLUBLE CANNABINOID PRODRUGS COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME | FETTEROLF, BRANDON J | — |
| 18430133 | PRODUCTION OF CANNABINOID GLYCOSIDE COMPOUNDS IN CELL CULTURE | KOVALENKO, MYKOLA V | — |
| 18364273 | WATER-SOLUBLE CANNABINOID FOOD AND BEVERAGE ADDITIVE HAVING ENHANCED STABILITY | MOEHLMAN, ANDREW TERRY | — |
| Art Unit | Apps |
|---|---|
| 1662 | 3 |
| 1626 | 1 |
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19290958 | Novel Systems, Methods, And Compositions For The Glycosylation Of Cannabinoid Compounds | DEVEAU ROSEN, JASON | 1662 | §112 | Non-Final OA | — | Pending | Aug 05, 2025 |
| 18678152 | WATER-SOLUBLE CANNABINOID PRODRUGS COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME | FETTEROLF, BRANDON J | 1626 | §102§112 | Non-Final OA | — | Pending | May 30, 2024 |
| 18430133 | PRODUCTION OF CANNABINOID GLYCOSIDE COMPOUNDS IN CELL CULTURE | KOVALENKO, MYKOLA V | 1662 | §103§112 | Non-Final OA | — | Pending | Feb 01, 2024 |
| 18364273 | WATER-SOLUBLE CANNABINOID FOOD AND BEVERAGE ADDITIVE HAVING ENHANCED STABILITY | MOEHLMAN, ANDREW TERRY | 1655 | §102§103§112DP | Non-Final OA | — | Pending | Aug 02, 2023 |
| 17189063 | Compositions And Methods For Glycosylating Cannabinoid Compounds | KOVALENKO, MYKOLA V | 1662 | §112 | Final Rejection | 11d overdue | Pending | Mar 01, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTrait Biosciences, Inc. has 5 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Mykola V Kovalenko has the most, with 2 of Trait Biosciences, Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
